Reactive oxygen species and insulin resistance: the good, the bad and the ugly

Tony Tiganis1

  • 1Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia. tony.tiganis@monash.edu

Insights

Reactive oxygen species (ROS) play a dual role in type 2 diabetes mellitus (T2DM), potentially worsening insulin resistance but also enhancing insulin sensitivity. Further research is needed to understand their complex effects.

Area of Science:

  • Biochemistry
  • Cellular Biology
  • Endocrinology

Background:

  • Reactive oxygen species (ROS) are implicated in type 2 diabetes mellitus (T2DM) pathogenesis.
  • ROS can impair insulin response and foster insulin resistance, a hallmark of T2DM.
  • Paradoxically, ROS are also vital for normal intracellular signaling pathways.

Purpose of the Study:

  • To review the dual role of ROS in modulating insulin sensitivity and resistance.
  • To explore the potential of hydrogen peroxide (H2O2) in improving insulin sensitivity.
  • To discuss the implications of antioxidant use in managing T2DM.

Main Methods:

  • Literature review of existing studies on ROS, insulin signaling, and T2DM.
  • Analysis of evidence regarding ROS generation by NADP(H) oxidases.
  • Examination of the effects of growth factors, cytokines, and hormones on ROS production.

Main Results:

  • ROS can both promote insulin resistance and enhance insulin sensitivity.
  • NADPH oxidases contribute to ROS generation crucial for intracellular signaling.
  • Evidence suggests H2O2 can improve insulin sensitivity in vivo.

Conclusions:

  • ROS exhibit a complex, context-dependent role in insulin response.
  • Targeting ROS pathways may offer therapeutic strategies for T2DM.
  • The widespread use of antioxidants requires careful consideration of potential complications.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...